C-MET pathway involvement in chronic rhinosinusitis: A genetic association analysis

Otolaryngology - Head and Neck Surgery (United States)

Volumn 142, Issue 5, 2010, Pages 665-671.e2

  Castano, Roberto ^a,b   Bossé, Yohan ^c,d   Endam, Leandra Mfuna ^a   Filali Mouhim, Abdelali ^a   Desrosiers, Martin ^a,e  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR RECEPTOR; SCATTER FACTOR;

ADULT; ALLELE; ARTICLE; CANADA; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; FEMALE; GENE; GENE CONSTRUCT; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TERTIARY HEALTH CARE; CHRONIC DISEASE; GENETICS; MIDDLE AGED; NOSE POLYP; RHINITIS; SINUSITIS;

CHRONIC DISEASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MET; RHINITIS; SINUSITIS;

EID: 77951900931     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1016/j.otohns.2010.01.004     Document Type: Article

References (25)

1. Gliklich RE, Metson R. Economic implications of chronic sinusitis. Otolaryngol Head Neck Surg 1998;118:344-9. (Pubitemid 28150743)
2. Desrosiers MY, Kilty SJ. Treatment alternatives for chronic rhinosi-nusitis persisting after ESS: what to do when antibiotics, steroids and surgery fail. Rhinology 2008;46:3-14.
3. Lin JC, Naujokas M, Zhu H, et al. Intron-exon structure of the MET gene and cloning of an alternatively-spliced Met isoform reveals frequent exon-skipping of a single large internal exon. Oncogene 1998; 16:833-42. (Pubitemid 28102586)
4. Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006;6:637-45. (Pubitemid 44140861)
5. Stankovic KM, Goldsztein H, Reh DD, et al. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope 2008;118:881-9. (Pubitemid 351674119)
6. Rho HS, Lee SH, Lee HM, et al. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps. Arch Otolaryngol Head Neck Surg 2006;132:985-9.
7. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131(6 suppl):S1-S62. (Pubitemid 39577605)
8. Al Shemari H, Bosse Y, Hudson TJ, et al. Influence of leukotriene gene polymorphisms on chronic rhinosinusitis. BMC Med Genet 2008; 9:21.
9. Bosse Y, Bacot F, Montpetit A, et al. Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans. Hum Genet 2009;125:305-18.
10. Croce CM. Oncogenes and cancer. N Engl J Med 2008;358:502-11. (Pubitemid 351185806)
11. Coste A, Lefaucheur JP, Wang QP, et al. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998;124:1361-6. (Pubitemid 28564112)
12. Coste A, Brugel L, Maitre B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 2000;15:367-72. (Pubitemid 30085967)
13. Coste A, Wang QP, Roudot-Thoraval F, et al. Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 1996;106:578-83. (Pubitemid 26137836)
14. Petruson B, Hansson HA, Petruson K. Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps. Acta Otolaryngol 1988;106:156-60.
15. Ishibashi T, Tanaka T, Nibu K, et al. Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 1998;107:885-90.
16. Sakamaki Y, Matsumoto K, Mizuno S, et al. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneu-monectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol 2002;26:525-33. (Pubitemid 34315859)
17. Pinto JM, Hayes MG, Schneider D, et al. A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope 2008;118:2067-72.
18. Reid LH, Gregg RG, Smithies O, et al. Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci USA 1990;87:4299-303.
19. Tanguay RL, Gallie DR. Translational efficiency is regulated by the length of the 3= untranslated region. Mol Cell Biol 1996;16: 146-56. (Pubitemid 126506960)
20. Kong-Beltran M, Stamos J, Wickramasinghe D. The Sema domain of Met is necessary for receptor dimerization and activation. Cancer Cell 2004;6:75-84. (Pubitemid 38903163)
21. Ma PC, Jagadeeswaran R, Jagadeesh S, et al. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res 2005;65:1479-88. (Pubitemid 40270177)
22. Ito W, Takeda M, Tanabe M, et al. Anti-allergic inflammatory effects of hepatocyte growth factor. Int Arch Allergy Immunol 2008; 146(suppl 1):82-7.
23. De Herdt MJ, Baatenburg de Jong RJ. HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma. Front Biosci 2008;13:2516-26. (Pubitemid 351599701)
24. Zeng Q, McCauley LK, Wang CY. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygen-ase-2. Implication in head and neck squamous cell carcinoma progression. J Biol Chem 2002;277:50137-42. (Pubitemid 36014467)
25. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.